SEC Form 4 · accession 0001213900-16-017130
Enochian Biosciences Inc · ENOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Jean Marie Leire
Officer — Chief Executive Officer · Director
Period of report
Sep 20, 2016
Accepted (ET)
Sep 29, 2016 · 1:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001527728
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $2.00 | Sep 20, 2016 | A | 300,000 | A | Sep 20, 2016 | Dec 31, 2019 | Common Stock | 300,000 | 300,000 | D |